- Home
- WCN vs TEVA Comparison
WCN vs TEVA Comparison
Compare WCN & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WCN | TEVA |
|---|---|---|
| Founded | 1997 | 1901 |
| Country | Canada | Israel |
| Employees | N/A | 32842 |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.0B | 39.2B |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | WCN | TEVA |
|---|---|---|
| Price | $154.47 | $32.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 8 |
| Target Price | ★ $204.21 | $38.63 |
| AVG Volume (30 Days) | 1.5M | ★ 4.6M |
| Earning Date | 04-22-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.85% | N/A |
| EPS Growth | ★ 74.48 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $9,466,915,000.00 | N/A |
| Revenue This Year | $6.14 | N/A |
| Revenue Next Year | $6.18 | $2.97 |
| P/E Ratio | $182.15 | ★ $28.19 |
| Revenue Growth | ★ 6.14 | N/A |
| 52 Week Low | $146.89 | $14.99 |
| 52 Week High | $191.91 | $37.35 |
Technical Indicators
Market Signals| Indicator | WCN | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 47.80 | 41.05 |
| Support Level | $147.86 | $30.53 |
| Resistance Level | $160.90 | $32.74 |
| Average True Range (ATR) | 3.05 | 1.12 |
| MACD | 0.51 | -0.21 |
| Stochastic Oscillator | 57.00 | 4.69 |
Price Performance
Historical ComparisonAbout WCN Waste Connections Inc.
Waste Connections is a North American waste management company focused on integrated waste collection services. The firm primarily focuses on residential, commercial, municipal, and industrial waste collection, with a secondary market focus on rural areas. With 113 landfills and 222 transfer stations as of 2024, it is the third-largest waste management company by revenue. Revenue is split among six operating segments: Western, Southern, Eastern, Central, Canada, and Midsouth.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.